235 related articles for article (PubMed ID: 18729185)
1. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.
Liao J; Li X; Koh AJ; Berry JE; Thudi N; Rosol TJ; Pienta KJ; McCauley LK
Int J Cancer; 2008 Nov; 123(10):2267-78. PubMed ID: 18729185
[TBL] [Abstract][Full Text] [Related]
2. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
Li X; Loberg R; Liao J; Ying C; Snyder LA; Pienta KJ; McCauley LK
Cancer Res; 2009 Feb; 69(4):1685-92. PubMed ID: 19176388
[TBL] [Abstract][Full Text] [Related]
3. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
4. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein.
Blomme EA; Dougherty KM; Pienta KJ; Capen CC; Rosol TJ; McCauley LK
Prostate; 1999 May; 39(3):187-97. PubMed ID: 10334108
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.
Park SI; Lee C; Sadler WD; Koh AJ; Jones J; Seo JW; Soki FN; Cho SW; Daignault SD; McCauley LK
Cancer Res; 2013 Nov; 73(22):6574-83. PubMed ID: 24072746
[TBL] [Abstract][Full Text] [Related]
7. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
Bhatia V; Saini MK; Shen X; Bi LX; Qiu S; Weigel NL; Falzon M
Mol Cancer Ther; 2009 Jul; 8(7):1787-98. PubMed ID: 19584236
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer.
Ongkeko WM; Burton D; Kiang A; Abhold E; Kuo SZ; Rahimy E; Yang M; Hoffman RM; Wang-Rodriguez J; Deftos LJ
PLoS One; 2014; 9(1):e85803. PubMed ID: 24465715
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.
Park SI; McCauley LK
Endocr Relat Cancer; 2012 Jun; 19(3):243-54. PubMed ID: 22291434
[TBL] [Abstract][Full Text] [Related]
10. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP).
Liao J; McCauley LK
Cancer Metastasis Rev; 2006 Dec; 25(4):559-71. PubMed ID: 17165129
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
Deftos LJ; Barken I; Burton DW; Hoffman RM; Geller J
Biochem Biophys Res Commun; 2005 Feb; 327(2):468-72. PubMed ID: 15629138
[TBL] [Abstract][Full Text] [Related]
12. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
[TBL] [Abstract][Full Text] [Related]
13. Effects of transforming growth factor-beta1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells.
Sellers RS; LeRoy BE; Blomme EA; Tannehill-Gregg S; Corn S; Rosol TJ
Prostate; 2004 Mar; 58(4):366-73. PubMed ID: 14968437
[TBL] [Abstract][Full Text] [Related]
14. Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.
Yan Z; Jin S; Wei Z; Huilian H; Zhanhai Y; Yue T; Juan L; Jing L; Libo Y; Xu L
Biochim Biophys Acta; 2014 Sep; 1842(9):1350-63. PubMed ID: 24787381
[TBL] [Abstract][Full Text] [Related]
15. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.
Shukeir N; Arakelian A; Kadhim S; Garde S; Rabbani SA
Cancer Res; 2003 May; 63(9):2072-8. PubMed ID: 12727822
[TBL] [Abstract][Full Text] [Related]
16. PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis.
Mak IW; Cowan RW; Turcotte RE; Singh G; Ghert M
PLoS One; 2011; 6(5):e19975. PubMed ID: 21625386
[TBL] [Abstract][Full Text] [Related]
17. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
18. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
19. PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro.
Lu Y; Xiao G; Galson DL; Nishio Y; Mizokami A; Keller ET; Yao Z; Zhang J
Int J Cancer; 2007 Aug; 121(4):724-33. PubMed ID: 17390372
[TBL] [Abstract][Full Text] [Related]
20. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer.
Iddon J; Bundred NJ; Hoyland J; Downey SE; Baird P; Salter D; McMahon R; Freemont AJ
J Pathol; 2000 Jun; 191(2):170-4. PubMed ID: 10861577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]